Search Results 721-730 of 21503 for Inhibition
Sildenafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. ... If you take sildenafil for pulmonary arterial hypertension, do not ...
Patients taking mast cell inhibitors and/or degranulation inhibitors for any reason; The presence of infections, highly communicable diseases (e.g. AIDS) ...
The scientific hypothesis for use of IMO-8400 to treat patients with Waldenström's macroglobulinemia depends on the inhibition ... inhibitor BGB-11417 in ...
Examples include studying the tight binding and inhibition of proteins, exploring the ability to trigger new cell responses, enhancing drug delivery, and ...
... inhibitors and ARB's is allowed within the 3 months prior to randomization. Pharmacological Therapy (as appropriate):. Angiotensin converting enzyme (ACE) ...
... inhibitor. These medicines are injected under the skin or through an intravenous line. Another option is a Janus kinase (JAK) inhibitor. JAK inhibitors are ...
difficile are twice as likely to get it again. Other known risk factors include proton-pump inhibitors for gastric reflux, immunosuppression, and long hospital ...
This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and requiring salvage therapy as assessed ...
So new guidelines have come out in recent years suggesting that some of the tried-and-true quadruple therapies which include a proton pump inhibitor ...
... inhibitors and inhibitors of receptors such as EGFR and IGFR1. Studies of CI1033, an EGFR tyrosine kinase inhibitor, combined with topoisomerase I ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.